Simplex Trading’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
CP
BFM
CM
Simplex Trading's ANIK Position: Q2 2026 in Review
Simplex Trading sold out of Anika Therapeutics (ANIK) in Q2 2026, closing a stake of 70 shares — an estimated $1.01K sold.
Simplex Trading first reported a position in ANIK in Q4 2014 and held it in 24 quarters. The position peaked at $343K in Q3 2017. 134 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.
- Simplex Trading reported no remaining Anika Therapeutics position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 70 Anika Therapeutics shares in Q2 2026, an estimated $1.01K.
- Simplex Trading first reported a position in Anika Therapeutics in Q4 2014 and held it in 24 quarters.
- Simplex Trading's Anika Therapeutics position peaked at $343K in Q3 2017.
- 134 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.